Cancer Research Institute Event Calendar



Finding an Immunotherapy Clinical Trial with Patrick Meins, Clinical Trial Navigator, EmergingMed

What are clinical trials? When is a clinical trial right for me? How do I talk to my doctor about clinical trials? What information do I need to have—and what information do the clinical trial organizers need? There are so many questions surrounding clinical trials for both patients and caregivers that need to be answered in order to make the right choice.

In this webinar, Patrick Meins, a Clinical Trial Navigator at EmergingMed, answers common questions around cancer clinical trials including trial definitions, eligibility criteria, and how to search for the right one. 

After receiving an MA in Spanish Philology and doing many odd jobs, Patrick Meins found his way into health care advocacy, starting with a local HIV/AIDS organization and moving on to working with the Cancer Information Service at the National Cancer Institute. In 2010, he began working as a Clinical Trials Navigator for cancer patients. He works with a wide range of patients, caregivers, and healthcare professionals to match to clinical trials that are specific to their own disease and treatment history. He has guided many through narrowing down trials that fit their needs. He is passionate about being able to help so many during these times.

The "Cancer Immunotherapy and You" webinar series is produced by the Cancer Research Institute and is made possible with generous support from Bristol-Myers Squibb, with additional support from Regeneron, Sanofi Genzyme, and Adaptimmune.

Browse our Cancer Immunotherapy and You Webinar Series playlist on YouTube or visit the Webinars page on our website to see other webinars in this series.

2018 Cancer Immunotherapy and You Webinar Series Sponsors Bristol-Myers Squibb, Sanofi Genzyme, Regeneron, Adaptimmune

Read more:

This website uses tracking technologies, such as cookies, to provide a better user experience. If you continue to use this site, then you acknowledge our use of tracking technologies. For additional information, review our Privacy Policy.